This review discusses the application and technical aspects of radiofrequency ablation for treating endocrine tumors.
May guide RFA technique in endocrine tumors; leaves open validation in prospective trials.
Radiofrequency ablation (RFA) relies on cell destruction using heat, which is generated by the vibration of electrons as a result of high-frequency electrical energy. RFA was initially employed for the treatment of arrhythmogenic cardiac lesions. It has since been used to treat solid tumors of various organs, both primary and metastatic. Here we review the manner in which RFA technology delivered through minimally invasive techniques has been applied to endocrine problems and discuss some technical points.
No takes yet. Share an insight, caveat, or question.
Wallace et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: